Cyanotech Corporation (CYAN) financial statements (2020 and earlier)
Company profile
| Business Address |
73-4460 QUEEN KAAHUMANU HWY KAILUA KONA, HI 96740 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 1,094 | 840 | 1,329 | 1,407 | 1,240 | 2,226 | ||
| Cash and cash equivalents | 1,094 | 840 | 1,329 | 1,407 | 1,240 | 2,226 | ||
| Receivables | 1,655 | 1,982 | 2,664 | 2,135 | 2,983 | 3,258 | ||
| Inventory, net of allowances, customer advances and progress billings | 11,129 | 11,274 | 9,034 | 7,972 | 7,856 | 5,678 | ||
| Inventory | 11,129 | 11,274 | 9,034 | 7,972 | 7,856 | 5,678 | ||
| Other undisclosed current assets | 448 | 496 | 590 | 722 | 576 | 632 | ||
| Total current assets: | 14,326 | 14,592 | 13,617 | 12,236 | 12,655 | 11,794 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 3,983 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 13,867 | 14,752 | 15,734 | 16,712 | 17,796 | 14,754 | ||
| Restricted cash and investments | 65 | |||||||
| Other noncurrent assets | 261 | 282 | 291 | 213 | 696 | 846 | ||
| Other undisclosed noncurrent assets | 3,521 | |||||||
| Total noncurrent assets: | 18,111 | 15,034 | 16,090 | 16,925 | 18,492 | 19,121 | ||
| TOTAL ASSETS: | 32,437 | 29,626 | 29,707 | 29,161 | 31,147 | 30,915 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 3,672 | 5,914 | 4,419 | 4,679 | 5,430 | 4,980 | ||
| Accounts payable | 2,838 | 4,922 | 3,527 | 3,666 | 4,000 | 2,926 | ||
| Accrued liabilities | 834 | 992 | 892 | 1,013 | 1,430 | 1,124 | ||
| Employee-related liabilities | 930 | |||||||
| Deferred revenue | 304 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 3,031 | 948 | 655 | 623 | 574 | 234 | ||
| Customer advances and deposits | ✕ | ✕ | 119 | 117 | 31 | |||
| Contract with customer, liability | ✕ | 626 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 2,000 | 633 | 611 | (930) | ||||
| Total current liabilities: | 7,007 | 9,488 | 5,707 | 6,032 | 6,121 | 4,315 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation, including: | 10,028 | 5,372 | 6,023 | 6,516 | 7,094 | 5,109 | ||
| Long-term debt, excluding current maturities | 6,349 | 57 | 103 | 116 | ||||
| Operating lease, liability | 3,679 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed long-term debt and lease obligation | 5,315 | 5,920 | 6,400 | 7,094 | 5,109 | |||
| Liabilities, other than long-term debt | 58 | 157 | 104 | 8 | ||||
| Deferred revenue and credits | ✕ | ✕ | 30 | 8 | ||||
| Deferred tax liabilities, net | ✕ | 157 | 74 | |||||
| Other liabilities | 58 | |||||||
| Other undisclosed noncurrent liabilities | (143) | (130) | (151) | |||||
| Total noncurrent liabilities: | 10,086 | 5,229 | 5,893 | 6,522 | 7,198 | 5,117 | ||
| Total liabilities: | 17,093 | 14,717 | 11,600 | 12,554 | 13,319 | 9,432 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | 15,344 | 14,909 | 18,107 | 16,607 | 17,828 | 21,483 | ||
| Common stock | 118 | 117 | 115 | 114 | 112 | 111 | ||
| Additional paid in capital | 32,786 | 32,447 | 32,051 | 31,577 | 31,585 | 30,846 | ||
| Accumulated deficit | (17,560) | (17,655) | (14,059) | (15,084) | (13,869) | (9,474) | ||
| Total stockholders' equity: | 15,344 | 14,909 | 18,107 | 16,607 | 17,828 | 21,483 | ||
| TOTAL LIABILITIES AND EQUITY: | 32,437 | 29,626 | 29,707 | 29,161 | 31,147 | 30,915 | ||
Income statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 31,864 | 30,202 | 34,115 | 32,042 | 31,840 | 33,809 | |
| Revenue, net | ✕ | ✕ | 32,042 | 31,840 | 33,809 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (18,781) | (19,736) | (20,744) | (19,818) | (19,974) | (19,343) | |
| Gross profit: | 13,083 | 10,466 | 13,371 | 12,224 | 11,866 | 14,466 | |
| Operating expenses | (13,451) | (13,463) | (11,957) | (12,906) | (12,651) | (14,144) | |
| Operating income (loss): | (368) | (2,997) | 1,414 | (682) | (785) | 322 | |
| Nonoperating expense | (499) | (528) | (282) | (93) | |||
| Interest and debt expense | (381) | (71) | (72) | (67) | (57) | (56) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 67 | 57 | 56 | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (749) | (3,068) | 843 | (1,210) | (1,067) | 229 | |
| Other undisclosed income (loss) from continuing operations before income taxes | (288) | (511) | 72 | ||||
| Income (loss) from continuing operations before income taxes: | (1,037) | (3,579) | 915 | (1,210) | (1,067) | 229 | |
| Income tax expense (benefit) | (53) | (17) | 110 | (5) | (3,328) | (253) | |
| Net income (loss) available to common stockholders, diluted: | (1,090) | (3,596) | 1,025 | (1,215) | (4,395) | (24) | |
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (1,090) | (3,596) | 1,025 | (1,215) | (4,395) | (24) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (1,090) | (3,596) | 1,025 | (1,215) | (4,395) | (24) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.